February 20, 2017 / 17:10 IST
Profit of Rs 17.6 bn received from stake sale in SBI Life helped buoy SBIN’s Q3PAT to Rs 26 bn. Loan growth remained muted (+4% YoY) due to 11% YoY decline in SME loans and largely flat large corporate book.
Outlook
We maintain BUY with SOTP-based TP of Rs 320 (16% upside from CMP), valuing the core book at 1.5x FY18E P/ABV and Life Insurance subsidiary at Rs 340 bn (25% discount to last deal value of Rs 460 bn). At CMP, SBIN trades at 1.3x FY18E P/ABV (adj. for investments and NPAs).
For all recommendations, click here Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Read More
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!